medigraphic.com
ISSN 1727-897X (Electronic)

2012, Number 5

<< Back Next >>

Medisur 2012; 10 (5)

Molecular Study of Sickle Cell Anemia. βS and βC Allele Frequency in Patients Studied in 2010

Cervera GIA, García HM, Collazo MT

Language: Spanish
References: 15
Page: 365-369
PDF size: 169.03 Kb.


ABSTRACT

Background: Sickle cell anemia is a genetic disease that is inherited in an autosomal recessive pattern. It occurs associated with episodes of acute pain and progressive damage to various organs. βS allelic variant is the most common cause of sickle cell disease. It is more common in Africans and their descendants.
Objective: To determine the frequency of allelic variants βS and βC in 270 DNA samples from fetuses conceived by couples at risk of having children affected with this hemoglobinopathy.
Methods: A descriptive study was conducted with 270 fetuses of couples carrying alleles S and / or C, from different provinces of Cuba, whose samples were sent from the Provincial Genetics Centers to the Laboratory of Molecular Biology at the National Center of Medical Genetics. We used the ARMS-PCR and PCR-RFLP methods to detect the presence of alleles βA, βS and βC, the variables of the study.
Results: We found that the frequency of the allele variant βS was of 0.38 while βC allelic variant showed a frequency of 0.08, which is consistent with the results obtained by different authors. Disease was diagnosed in 60 fetuses.
Conclusions: The mothers whose fetuses were detected with sickle cell disease, received genetic counseling regarding the disease course. They were also offered the option of elective pregnancy termination. In case they did not decide to do it, the possibility of differential and appropriate treatment to child right from birth was offered.


REFERENCES

  1. Pawloski JR, Hess DT, Stamler JS. Impaired vasodilation by red blood cells in sickle cell disease. Proc Natl Acad Sci U S A. 2005 ; 102 (7): 2531-6. [Buscar en Google Scholar]

  2. Rees DC, Williams TN, Gladwin MT. Sickle cell disease. Lancet. 2010 ; 376 (9757): 2018-31. [Buscar en Google Scholar]

  3. Durán CL, Morales OL, Echeverri SJ, Isaza M. Haplotipos del gen de la globina beta en portadores de hemoglobina S en Colombia. Biomédica [revista en Internet]. 2012 [ cited 28 Sep 2012 ] ; 32 (1): [aprox. 19p]. Avaidable from: http://www.revistabiomedica.org/index.php/biomedica/article/view/600/852. [Buscar en Google Scholar]

  4. Koopmans J, Ross LF. Identification and management of sickle cell trait by young physicians. J Natl Med Assoc. 2012 ; 104 (5-6): 299-304. [Buscar en Google Scholar]

  5. Pace BS, Ofori-Acquah SF, Peterson KR. Sickle cell disease: genetics, cellular and molecular mechanisms, and therapies. Anemia [revista en Internet]. 2012 [ cited 28 Sep 2012 ] [aprox. 2p]. Avaidable from: http://www.hindawi.com/journals/ane/2012/143594/. [Buscar en Google Scholar]

  6. Wood ET, Stover DA, Slatkin M, Nachman MW, Hammer MF. The beta-globin recombinational hotspot reduces the effects of strong selection around the HbC, a recently arisen mutation providing resistance to malaria. Am J Hum Genet. 2005 ; 77 (4): 637-42. [Buscar en Google Scholar]

  7. Trompeter S, Roberts I. Haemoglobin F modulation in childhood sickle cell disease. Br J Haematol. 2008 ; 144 (4): 308-16. [Buscar en Google Scholar]

  8. Granda H, Gispert S, Dorticós A, Martín MR, Cuadras Y, Calvo M, et al. A Cuban programme for prevention of sickle cell disease. Lancet. 1991 ; 337 (8734): 152-3. [Buscar en Google Scholar]

  9. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleoted cells. Nucleic Acids Res. 1988 ; 16 (21): 1215-18. [Buscar en Google Scholar]

  10. Wu DY, Ugozzoli L, Pal BK, Wallace RB. Allele-specific enzymatic amplification of ß-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci USA. 1989 ; 86 (8): 2757-60. [Buscar en Google Scholar]

  11. Suardíaz J, Cruz C, Colina A. Laboratorio Clínico. La Habana: Editorial Ciencias Médicas; 2004. p. 253-6. [Buscar en Google Scholar]

  12. Espinosa Martínez E, Svarch E, Martínez Antuña G, Hernández Ramírez P. La anemia drepanocítica en Cuba. Experiencia de 30 años. Rev Cubana Hematol Inmunol Hemoter [revista en Internet]. 1997 [ cited 13 Mar 2012 ] ; 12 (2): [aprox. 9p]. Avaidable from: http://bvs.sld.cu/revistas/hih/vol12_2_96/hih05296.htm. [Buscar en Google Scholar]

  13. Marcheco Teruel B. El Programa Nacional de Diagnóstico, Manejo y Prevención de Enfermedades Genéticas y Defectos Congénitos en Cuba: 1981-2009. Rev Cubana de Genét Comunit. 2009 ; 3 (2-3): 167-84. [Buscar en Google Scholar]

  14. Rodríguez Vázquez M, Martín García D, Pairol Acosta I. Programa de diagnóstico, manejo y prevención de enfermedades genéticas y defectos congénitos en la provincia de Sancti Spíritus: 1985-2007. Rev Cubana de Genét Comunit [revista en Internet]. 2009 [ cited 13 Mar 2012 ] ; 3 (2-3): [aprox. 8p]. Avaidable from: http://www.bvs.sld.cu/revistas/rcgc/v3n2_3/rcgc0723010%20esp.html. [Buscar en Google Scholar]

  15. Lima Rodríguez U. El programa de diagnóstico, manejo y prevención de enfermedades genéticas y defectos congénitos en la provincia Ciego de Ávila: 1986-2007. Rev Cubana de Genét Comunit [revista en Internet]. 2009 [ cited 13 Ene 2012 ] ; 3 (2-3): [aprox. 7p]. Avaidable from: http://www.bvs.sld.cu/revistas/rcgc/v3n2_3/rcgc0923010%20esp.htm. [Buscar en Google Scholar]




2020     |     www.medigraphic.com